Tumor-intrinsic-resistant mechanisms involve low tumor mutational burden, compromised antigen presentation machinery, alterations in the interferon-gamma pathway, and loss of tumor suppressors such as STK11/LKB1 [13]. The gene discussed is IFNG; the disease is neoplasm.